Purdue Pharma and Sackler Family Agree to $7.4 Billion Settlement
#OpioidsCrisis #PurduePharmaPurdue Pharma and the Sackler family have agreed to a new $7.4 billion settlement over the opioids crisis, a $1 billion increase from a previous deal. The settlement, pending court approval, requires the family to contribute more and give up Purdue's ownership. read more
Former McKinsey Partner Pleads Guilty in Purdue Pharma Case
#OpioidsCrisis #McKinseyGuiltyMartin Elling, a former McKinsey & Co partner, pleaded guilty to destroying records related to advice on boosting OxyContin sales for Purdue Pharma in 2013. A month after McKinsey's $650m settlement for related charges, Elling faces up to a year in prison. read more
McKinsey nears $600+ million settlement over opioid sales allegations
#McKinsey #OpioidsCrisisMcKinsey nears $600m settlement with US government over its role in the opioid crisis. The consultancy firm is accused of aiding opioid manufacturers in boosting sales, contributing to the epidemic. The settlement includes civil violations and potential dismissal of criminal charges. read more
Global Emergence of Deadly Nitazene Opioids Sparks Urgency for Detection
#Nitazenes #OpioidsCrisisA new class of synthetic opioids, nitazenes, potentially more potent than fentanyl, emerges globally raising concerns of a new drug crisis. Scientists scramble to detect these opioids in the drug supply amidst recent overdoses and the need for harm reduction measures. read more
#OpioidsCrisis #DrugOverdose
More than 1 million Americans have died from drug overdoses since 2001, with over 100,000 deaths in 2023. The decrease in overdose deaths in 2023 offers a glimmer of hope, although challenges with synthetic opioids like fentanyl persist. read more